As of 2025-11-04, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 13.9x | 12.4x |
| Forward P/E multiples | 7.7x - 17.6x | 13.5x |
| Fair Price | (501.76) - (932.01) | (866.29) |
| Upside | -2143.8% - -3896.4% | -3628.7% |
| Date | EV/EBITDA |